1. In Systemic Sclerosis, a Unique Long Non Coding RNA Regulates Genes and Pathways Involved in the Three Main Features of the Disease (Vasculopathy, Fibrosis and Autoimmunity) and in Carcinogenesis
    Marzia Dolcino et al, 2019, Journal of Clinical Medicine CrossRef
  2. A Novel Strategy for Regulating mRNA’s Degradation via Interfering the AUF1’s Binding to mRNA
    Kun-Tao Li et al, 2022, Molecules CrossRef
  3. Alteration in the expression of microRNA-21 regulated target genes: Role in breast cancer
    PRIYANKA THAKUR et al, 2022, BIOCELL CrossRef
  4. miR-877-5p Inhibits Epithelial Mesenchymal Transformation of Breast Cancer Cells by Targeting FGB
    Haixia Liu et al, 2022, Disease Markers CrossRef
  5. 7‐Methoxy‐luteolin‐8‐C‐β‐6‐deoxy‐xylo‐pyranos‐3‐uloside exactly (mLU8C‐PU) isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP‐9 and IL‐8 expression in MCF‐7 breast cancer cells
    Soo‐Jin Kim et al, 2018, Environmental Toxicology CrossRef
  6. Acetylshikonin inhibits the migration and invasion of A375 cells by reversing EMT process via the PI3K/Akt/mTOR pathway
    Shuang Jiang et al, 2019, Biotechnology & Biotechnological Equipment CrossRef
  7. MiR-942 regulates the function of breast cancer cell by targeting FOXA2
    Jinku Zhang et al, 2019, Bioscience Reports CrossRef
  8. Regulation of breast cancer metastasis signaling by miRNAs
    Belinda J. Petri et al, 2020, Cancer and Metastasis Reviews CrossRef
  9. A comprehensive review on oncogenic miRNAs in breast cancer
    Maryam Nurzadeh et al, 2021, Journal of Genetics CrossRef
  10. miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
    Erik Kudela et al, 2020, International Journal of Molecular Sciences CrossRef
  11. Contribution of miRNAs in the Pathogenesis of Breast Cancer
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
  12. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells
    Yihan Wang et al, 2018, Cell Cycle CrossRef
  13. Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Yongheng Liu et al, 2022, Cancer Cell International CrossRef
  14. MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
    Chonggao Yin et al, 2018, Thoracic Cancer CrossRef
  15. Non-coding RNAs as potential therapeutic targets in breast cancer
    Deepti Tomar et al, 2020, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  16. RNA interference: Promising approach for breast cancer diagnosis and treatment
    Elham Allahyari et al, 2023, Cell Biology International CrossRef
  17. Role of miR-100-5p and CDC25A in breast carcinoma cells
    Xiaoping Li et al, 2022, PeerJ CrossRef
  18. Apatinib inhibits macrophage-mediated epithelial–mesenchymal transition in lung cancer
    Shuliang Liu et al, 2018, RSC Advances CrossRef
  19. miRNA‑520c‑3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A
    Xiaohan Sun et al, 2019, Oncology Letters CrossRef
  20. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis
    Shangwen Xiao et al, 2020, Bioscience Reports CrossRef
  21. Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer
    Anthony Ambesi et al, 2022, Cells CrossRef
  22. Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer
    Yujie Zhong et al, 2021, Molecular Oncology CrossRef
  23. Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axis
    Yang Liu et al, 2022, Molecular Therapy - Nucleic Acids CrossRef